Pharmacokinetics of clivarin® a new low molecular weight heparin in healthy volunteers
- 1 January 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 73 (2) , 95-108
- https://doi.org/10.1016/0049-3848(94)90084-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparative Human Pharmacology of Low Molecular Weight HeparinsSeminars in Thrombosis and Hemostasis, 1989
- Comparative pharmacology of low molecular weight heparins : Implications of manufacturing processes on biological effectsThrombosis Research, 1989
- Ambulante Langzeitprophylaxe der Thromboembolie mit niedermolekularem HeparinJournal of Molecular Medicine, 1987
- Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersThrombosis Research, 1986
- Clinical Efficacy of Heparin Fractions: Issues and AnswersCRC Critical Reviews in Clinical Laboratory Sciences, 1986
- Anticoagulant effects of two types of low molecular weight heparin administered subcutaneouslyThrombosis Research, 1983
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962